Infection Prevention Leade | STERIS plc, a key player in healthcare infection prevention, showcases consistent growth and financial stability in a critical market secto |
Financial Resilience | Explore STERIS's track record of mid-single-digit sales growth and double-digit EPS growth, with analyst price targets ranging from $265 to $280 |
Market Positioning | Delve into STERIS's premium valuation, driven by its non-elective product portfolio and strong execution in the healthcare and life sciences industries |
Challenges Ahead | Learn about STERIS's strategies to navigate ongoing EtO litigation, rising input costs, and evolving regulatory environments while maintaining market leadership |
Metrics to compare | STE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.1x | 30.8x | −0.5x | |
PEG Ratio | 0.93 | 0.24 | 0.00 | |
Price/Book | 2.8x | 2.5x | 2.6x | |
Price / LTM Sales | 3.4x | 2.3x | 3.0x | |
Upside (Analyst Target) | 29.8% | 23.2% | 58.6% | |
Fair Value Upside | Unlock | 28.3% | 10.2% | Unlock |
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.